
Table of contents
- Appendix A: Doping control statistics 2001–01 to 2010–11
- Appendix B: Publicly announced anti-doping rule violations 2010–11
- Appendix C: International anti-doping and doping control
- Appendix D: Powers of the Minister to give directions to ASADA and the CEO
- Appendix E: ASADA and CEO functions, powers and delegations
- Appendix F: Staffing statistics at 30 June 2011
- Appendix G: Occupational health and safety
- Appendix H: Advertising and market research
- Appendix I: Ecologically sustainable development and environmental performance
- Appendix J: Freedom of information
- Appendix K: Australian Sports Drug Medical Advisory Committee – functions
- Appendix L: Australian Sports Drug Medical Advisory Committee – Therapeutic Use Exemptions (TUEs) granted
- Appendix M: Anti-Doping Rule Violation Panel – functions
- Appendix N: Expenses and resources for Outcome 1
- Appendix O: ASADA Resource Statement 2010–11
Tables
- Table 1: Program 1.1 qualitative deliverables
- Table 2: Program 1.1 quantitative deliverables
- Table 3: Program 1.1 qualitative key performance indicators
- Table 4: Program 1.1 quantitative key performance indicators
- Table 5: Online substance searches and visitors
- Table 6: Education activities undertaken during 2010–11
- Table 7: Satisfaction with ASADA education
- Table 8: Anti-doping tests conducted by ASADA in 2010–11
- Table 9: Doping control facts and figures 2010–11
- Table 10: Substances involved in anti-doping matters 2010–11
- Table 11: Breakdown of anti-doping rule violations 2010–11
- Table 12: Expenditure on new and existing consultancy contracts 2010–11
- Table 13: Consultancy services let during 2010–11 of $10,000 or more
- Table 14: ADRVP attendance 2010–11
- Table 15: ADRVP expenses 2010–11
- Table 16: ASDMAC members
- Table 17: ASDMAC expenses 2010–11
- Table 18: ASDMAC freedom of information statistics
- Table 19: Doping control statistics
- Table 20: Publicly announced anti-doping rule violations
- Table 21: Entries on Register of Findings 2009–10 where the outcomes were to be advised
- Table 22: Government-to-government arrangements
- Table 23: Full-time and part-time staff at 30 June 2011
- Table 24: Staff by classification groups and location at 30 June 2011
- Table 25: SES staff at 30 June 2011
- Table 26: Staff in equal employment opportunity groups at 30 June 2011
- Table 27: Salary ranges of employees
- Table 28: Number of staff in the collective agreement or Section 24(1) determinations
- Table 29: Advertising and market research
- Table 30: ASADA freedom of information statistics
- Table 31: Therapeutic use exemptions granted
- Table 32: Substances and methods approved for therapeutic use 2010–11
- Table 33: Expenses and resources for Outcome 1
- Table 34: ASADA Resource Statement
Figures
- Figure 1: Australia’s anti-doping framework
- Figure 2: Outcome and program structure 2010–11
- Figure 3: Number of athletes and support personnel recording anti-doping rule violations
- Figure 4: Organisational structure at 30 June 2011
Top of page